NASAREL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Nasarel, and what generic alternatives are available?

Nasarel is a drug marketed by Teva Branded Pharm and is included in one NDA.

The generic ingredient in NASAREL is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nasarel

A generic version of NASAREL was approved as flunisolide by BAUSCH on February 20^th, 2002.

Try a Trial

Summary for NASAREL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	48
Patent Applications:	5,387
Formulation / Manufacturing:	see details
DailyMed Link:	NASAREL at DailyMed

Drug patent expirations by year for NASAREL

Anatomical Therapeutic Chemical (ATC) Classes for NASAREL

R01AD	Corticosteroids
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

R03BA	Glucocorticoids
R03B	OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R	Respiratory system

US Patents and Regulatory Information for NASAREL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	NASAREL	flunisolide	SPRAY, METERED;NASAL	020409-001	Mar 8, 1995		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NASAREL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	NASAREL	flunisolide	SPRAY, METERED;NASAL	020409-001	Mar 8, 1995	⤷ Try a Trial	⤷ Try a Trial
Teva Branded Pharm	NASAREL	flunisolide	SPRAY, METERED;NASAL	020409-001	Mar 8, 1995	⤷ Try a Trial	⤷ Try a Trial
Teva Branded Pharm	NASAREL	flunisolide	SPRAY, METERED;NASAL	020409-001	Mar 8, 1995	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NASAREL

See the table below for patents covering NASAREL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
New Zealand	183905	AEROSOL COMPOSITIONS FOR NASAL OR INHALATION ADMINISTRATION CONTAINING 6 -FLUORO-11 , 21-DIHYDROXY-16 ,17 -ISOPROPYLIDENEDIOXY-PREGNA-1,4-DIENE-3,20-DIONE	⤷ Try a Trial
Sweden	421426	SETT ATT FRAMSTELLA EN UNIK KRISTALLINISK POLYMORF FORM AV ALFA-FLUOR-11BETA, 21-DIHYDROXI-16ALFA, 17ALFA-ISOPROPYLENDIOXI-1,4-DIEN-3,20-DION	⤷ Try a Trial
New Zealand	180946	6 -FLUORO-11 ,21-DIHYDROXY-16 ,17 -ISOPROPYLIDENEDI-OXY-PREGNA-1,4-DIEN-3,20-DIONE HAVING POLYMORPHIC FORM-FORM A	⤷ Try a Trial
Ireland	871335		⤷ Try a Trial
Finland	872231		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for NASAREL

Anatomical Therapeutic Chemical (ATC) Classes for NASAREL

Make Better Decisions: Try a trial or see plans & pricing